The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 23, 2007
Filed:
Feb. 10, 2000
Bang Luu, Strasbourg, FR;
Gaby Schmitt, Strasbourg, FR;
Florence Keyling-bilger, Strasbourg, FR;
Celine Girlanda-junges, Strasbourg, FR;
Jean-philippe Loeffler, Strasbourg, FR;
Bernadette Lutz-bucher, Strasbourg, FR;
Jose-luis Gonzalez DE Aguilar, Strasbourg, FR;
Masashi Yamada, Tokyo, JP;
Yukie Suma, Tokyo, JP;
Philippe Chabert, Strasbourg, FR;
Bang Luu, Strasbourg, FR;
Gaby Schmitt, Strasbourg, FR;
Florence Keyling-Bilger, Strasbourg, FR;
Celine Girlanda-Junges, Strasbourg, FR;
Jean-Philippe Loeffler, Strasbourg, FR;
Bernadette Lutz-Bucher, Strasbourg, FR;
Jose-Luis Gonzalez de Aguilar, Strasbourg, FR;
Masashi Yamada, Tokyo, JP;
Yukie Suma, Tokyo, JP;
Philippe Chabert, Strasbourg, FR;
Meiji Dairies Corporation, Tokyo, JP;
Abstract
A preventive and therapeutic drug for a neurodegenerative disease containing, as an active ingredient, a cyclohexenone long-chain alcohol compound represented by formula (1) wherein each of R, R, and Rrepresents a hydrogen atom or a methyl group; and X represents a C10–C28 alkylene group or alkenylene group. Since the compound of the present invention exhibits excellent neurite-extension ability and an inhibition effect on disorders caused by mutation in an SOD gene, it is useful as the active ingredient of a preventive and therapeutic drug for neurodegenerative diseases, inter alia, amyotrophic lateral sclerosis, and as the active ingredient of an inhibitory drug for disorders caused by mutation in an SOD gene.